About

Why Benin?

Benin currently imports all of its injectable solutions. Producing locally changes things for patients.

  • 100%

    of the injectable solutions used in Benin are imported

  • 0

    local maker of liquid pharmaceutical solutions before TILAMED

  • 15countries

    in West Africa to supply from Benin

  • 400M +

    people in West Africa

The situation

A heavy product that is costly to import

An infusion solution is mostly water. It is heavy and bulky: shipping it is expensive because freight is charged by weight and volume, and storing it takes a lot of space. Yet wholesalers must permanently hold several months of stock to avoid shortages.

Today · imported

  1. 01Manufactured abroad
  2. 02Sea freight charged by weight and volume
  3. 03Several months of stock at wholesalers
  4. 04Hospitals and patients

Tomorrow · made in Benin

  1. 01Manufactured in Sèmè-Podji
  2. 02Delivered by road, to match real demand
  3. 03Hospitals and patients

The benefits

What local production changes

  • 01

    Availability

    Stock close at hand, delivered to match real demand, without months of delay.

  • 02

    Traceability

    A short, controlled supply chain that helps fight falsified medicines.

  • 03

    Price

    Less freight, less storage, fewer currency losses: fairer prices.

  • 04

    Jobs

    Skilled jobs and a transfer of industrial know-how.

On the Abidjan – Lagos coastal corridor
  1. AbidjanCôte d’Ivoire
  2. AccraGhana
  3. LoméTogo
  4. CotonouBeninPort
  5. Sèmè-PodjiTILAMED Pharma plant
  6. Border
  7. LagosNigeria
Atlantic Ocean

A strategic location

At the heart of West Africa

Our plant is being built in Sèmè-Podji, between Cotonou and the Nigerian border: a location chosen to supply the whole region.

  • Nigeria on the doorstep

    The site borders Africa's most populous country.

  • Close to the Port of Cotonou

    The country's main trade gateway, for raw materials and equipment alike.

  • A whole region to serve

    Fifteen countries and more than 400 million people supplied from a single plant.

Regional presence

The framework

A supportive environment

  1. 01

    A clear political will to develop a national pharmaceutical industry.

  2. 02

    An investment code that lists health and industrial processing among priority sectors.

  3. 03

    Customs and tax advantages in special economic zones.

  4. 04

    A young, skilled workforce trained in universities in the region and beyond.

Health sovereignty

The COVID-19 crisis showed how dependence on imports weakens health systems. Producing locally secures access to essential medicines.